Radiopharmaceuticals are special, but is this recognized? The possible impact of the new Clinical Trials Regulation on the preparation of radiopharmaceuticals C. DecristoforoI. PenuelasA. Chiti Editorial 03 July 2014 Pages: 2005 - 2007
Pretreatment metabolic tumour volume is predictive of disease-free survival and overall survival in patients with oesophageal squamous cell carcinoma Charles LemarignierFrédéric Di FiorePierre Vera Original Article 19 July 2014 Pages: 2008 - 2016
Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma Myriam SasanelliMichel MeignanEmmanuel Itti Original Article 06 June 2014 Pages: 2017 - 2022
Performance of FDG PET/CT at initial diagnosis in a rare lymphoma: nodular lymphocyte-predominant Hodgkin lymphoma Jean François GrellierLaetitia VercellinoPauline Brice Original Article 26 June 2014 Pages: 2023 - 2030
Advantage of FMISO-PET over FDG-PET for predicting histological response to preoperative chemotherapy in patients with oral squamous cell carcinoma Jun SatoYoshimasa KitagawaNagara Tamaki Original Article 28 May 2014 Pages: 2031 - 2041
Prognostic value of tumour blood flow, [18F]EF5 and [18F]FDG PET/CT imaging in patients with head and neck cancer treated with radiochemotherapy Gaber KomarKaisa LehtiöHeikki Minn Original Article 05 June 2014 Pages: 2042 - 2050
Metabolic parameters using 18F-FDG PET/CT correlate with occult lymph node metastasis in squamous cell lung carcinoma Do-Hoon KimBong-Il SongByeong-Cheol Ahn Original Article 03 July 2014 Pages: 2051 - 2057
Role of [18F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer Carlos CaicedoMaria Jose Garcia-VellosoJose Luis Perez Gracia Original Article 03 July 2014 Pages: 2058 - 2065
Impact of 18F-FDG PET/CT on the management of adrenocortical carcinoma: analysis of 106 patients Satoshi TakeuchiAparna BalachandranHubert H. Chuang Original Article 03 July 2014 Pages: 2066 - 2073
Furosemide diminishes 18F-fluoroethylcholine uptake in prostate cancer in vivo H. Christian RischkeTeresa BeckCordula A. Jilg Original Article 21 June 2014 Pages: 2074 - 2082
18F-Fluorocholine PET/CT for localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism: a pilot study Luka LezaicSebastijan RepJure Fettich Original Article 26 July 2014 Pages: 2083 - 2089
Evaluation of response to immunotherapy: new challenges and opportunities for PET imaging Laura GilardiChiara Maria GranaGiovanni Paganelli Editorial 11 July 2014 Pages: 2090 - 2092
89Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer Neeta Pandit-TaskarJoseph A. O’DonoghueSteven M. Larson Original Article 21 August 2014 Pages: 2093 - 2105
213Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience C. KratochwilF. L. GieselA. Morgenstern Original Article Open access 29 July 2014 Pages: 2106 - 2119
Astrocytosis measured by 11C-deprenyl PET correlates with decrease in gray matter density in the parahippocampus of prodromal Alzheimer’s patients IL Han ChooStephen F. CarterAgneta Nordberg Original Article 31 July 2014 Pages: 2120 - 2126
Comparing amyloid-β deposition, neuroinflammation, glucose metabolism, and mitochondrial complex I activity in brain: a PET study in aged monkeys Hideo TsukadaShingo NishiyamaNorihiro Harada Original Article 12 June 2014 Pages: 2127 - 2136
Do CSF levels of t-Tau, p-Tau and β1-42 amyloid correlate with dopaminergic system impairment in patients with a clinical diagnosis of Parkinson disease? A 123I-FP-CIT study in the early stages of the disease Agostino ChiaravallotiAlessandro StefaniOrazio Schillaci Original Article 10 July 2014 Pages: 2137 - 2143
The effect of 18F-florbetapir dose reduction on region-based classification of cortical amyloid deposition K. HerholzR. EvansJ. C. Matthews Original Article 08 July 2014 Pages: 2144 - 2149
Molecular imaging: the emerging role of optical imaging in nuclear medicine Fijs W. B. van LeeuwenMarion de Jongon behalf of the EANM Translational Molecular Imaging Committee; Marion de Jong, Fijs van Leeuwen, Tony Lahoutte, Laura Evangelista, Jacques Barbet, Silvana Del Vecchio, Roger Schibli. Editorial 19 July 2014 Pages: 2150 - 2153
Interim FDG PET scans in lymphoma: SUV measurement error may impair qPET methodology Eric LaffonRoger Marthan Letter to the Editor 12 August 2014 Pages: 2154 - 2154
Sources of variability in FDG PET imaging and the qPET value: reply to Laffon and Marthan Dirk HasencleverLars KurchRegine Kluge Letter to the Editor 12 August 2014 Pages: 2155 - 2157
FDG PET/CT methodology for evaluation of treatment response in lymphoma: from “graded visual analysis” and “semiquantitative SUVmax” to global disease burden assessment Sandip BasuHabib ZaidiAbass Alavi Letter to the Editor 04 July 2014 Pages: 2158 - 2160
Paolo Pozzilli, Andrea Lenzi, Bart L. Clarke, William F. Young Jr. (Eds): Imaging in Endocrinology Manuela AmatoLuigi Mansi Book Review 04 June 2014 Pages: 2161 - 2161
Wieslaw L. Nowinski and Beng Choon Chua (eds): The Human Brain in 1969 Pieces. Structure, Vasculature, Tracts, Cranial Nerves, Systems, Head Muscles, and Glands, Version 2.0 Luigi Mansi Book Review 04 June 2014 Pages: 2162 - 2162
Weibo Cai (Ed.): Engineering in Translational Medicine Luigi Mansi Book Review 17 July 2014 Pages: 2163 - 2163
Erratum to: Role of [18F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer Carlos CaicedoMaria Jose Garcia-VellosoJose Luis Perez-Gracia Erratum 16 September 2014 Pages: 2164 - 2164
Erratum to: Do CSF levels of t-Tau, p-Tau and β1–42 amyloid correlate with dopaminergic system impairment in patients with a clinical diagnosis of Parkinson disease? A 123I-FP-CIT study in the early stages of the disease Agostino ChiaravallotiAlessandro StefaniOrazio Schillaci Erratum 19 September 2014 Pages: 2165 - 2166
Widespread vascular inflammation in a patient with antineutrophil cytoplasmic antibody-associated vasculitis as detected by positron emission tomography Soile P. SalomäkiJukka KemppainenLaura Pirilä Image of the Month 18 July 2014 Pages: 2167 - 2168
Ideas from the second UEMS conference on CME/CPD: new EU directives on a patients’ rights in cross-border healthcare and professional qualifications Teresio VarettoDurval C. Costa UEMS/EBNM 31 July 2014 Pages: 2169 - 2173
Introduction to EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD) Arturo Chiti Editorial 21 August 2014 Pages: 2174 - 2174
EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD) Sergio ToddeAlbert D. WindhorstPhilip H. Elsinga Guidelines 01 August 2014 Pages: 2175 - 2185